Edwards Lifesciences Net Cash Flow from Operations Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.22  0.09  0.0787%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Cash Flow from Operations of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from operating activities, from continuing and discontinued operations.
View

837.9 M

            10 Years Trend  
Increasing
Slightly volatile
 Net Cash Flow from Operations 
      Timeline 

Edwards Lifesciences Net Cash Flow from Operations Over Time

2015-12-31  549,700,000 
2016-12-31  704,400,000 
2017-12-31  837,900,000 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  428,458,333
Geometric Mean  340,187,698
Coefficient Of Variation  69.01
Mean Deviation  240,784,722
Median  362,100,000
Standard Deviation  295,696,852
Range  921,100,000
R Value  0.87
R Squared  0.75
Significance  0.00027408
Slope  70,991,958

Currently Trending

MARA   
 NCM 
Sold over 500 shares of
3 hours ago ago
Traded for 5.74
TWTR   
 NYQ 
Sold over 100 shares of
3 hours ago ago
Traded for 22.58
FB   
 NMS 
Sold few shares of
3 hours ago ago
Traded for 178.39